Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis
Open Access
- 1 July 1999
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (7) , 1322-1328
- https://doi.org/10.1002/1529-0131(199907)42:7<1322::aid-anr4>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trialThe Lancet, 1999
- Leflunomide Inhibits Pyrimidine de Novo Synthesis in Mitogen-stimulated T-lymphocytes from Healthy HumansJournal of Biological Chemistry, 1998
- Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Journal of Clinical Investigation, 1998
- Molecular therapeutics. Methotrexate and its mechanism of actionArthritis & Rheumatism, 1996
- Leflunomide interferes with pyrimidine nucleotide biosynthesisInflammation Research, 1995
- Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activityArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Assessment of patient satisfaction in activities of daily living using a modified stanford health assessment questionnaireArthritis & Rheumatism, 1983
- Preliminary criteria for clinical remission in rheumatoid arthritisArthritis & Rheumatism, 1981